John Militello, See Remarks at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 48,759 shares at $3.96 ($193K) on 2025-10-14, disclosed to the SEC on 2025-10-16.
Open-market sale of $193k RCKT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.96 | 19,841 | $79K | 40.7% |
| 2 | $3.96 | 19,841 | $79K | 40.7% |
| 3 | $3.97 | 3,005 | $12K | 6.2% |
| 4 | $3.97 | 5,514 | $22K | 11.3% |
| 5 | $3.98 | 558 | $2K | 1.1% |
| Total | $3.96 avg | 48,759 |
| $193K |
| 100% |
| Filing → |
| RCKT | SELL | 2026-02-20 | $4K | — | Filing → |
| RCKT | SELL | 2026-02-18 | $12K | — | Filing → |
| RCKT | SELL | 2025-11-20 | $3K | — | Filing → |